The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer
Cancers · 26.02.2024 · 16 (5) · 939
DOI: 10.3390/cancers16050939 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.02.2024. Verfasst von Haidar Al Saffar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The review examines the vital role of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in the diagnosis, staging, and treatment of prostate cancer (PCa). It focuses on the superior diagnostic abilities of PSMA PET/CT for identifying both nodal and distant PCa, and its potential as a prognostic indicator for biochemical recurrence and overall survival. Additionally, we focused on the variability of PSMA’s expression and its impact on personalised treatment, particularly the use of [177Lu] Lu-PSMA-617 radioligand therapy. This review emphasises the essential role of PSMA PET/CT in enhancing treatment approaches, improving patient outcomes, and reducing unnecessary interventions, positioning it as a key element in personalised PCa management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia.
- Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia.
- Department of Surgery, Austin Health, Heidelberg, VIC 3084, Australia.
- School of Medicine and Health Sciences, Tecnologico de Monterrey, Monterrey 64849, Mexico.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3052, Australia.
- Department of Surgery (Urology), Royal Melbourne Hospital, Melbourne, VIC 3052, Australia.
ORCID-Profile: David C Chen, Carlos Delgado, Nathan Lawrentschuk
Zitieren
APA
Al Saffar, H., Chen, D. C., Delgado, C., Ingvar, J., Hofman, M. S., Lawrentschuk, N., Perera, M., Murphy, D. G., & Eapen, R. (2024). The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer. Cancers, 16(5), 939. https://doi.org/10.3390/cancers16050939
Vancouver
Al Saffar H, Chen DC, Delgado C, Ingvar J, Hofman MS, Lawrentschuk N, et al. The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer. Cancers. 2024;16(5):939. doi:10.3390/cancers16050939
BibTeX
@article{AlSaffar2024,
author = {Al Saffar, Haidar and Chen, David C and Delgado, Carlos and Ingvar, Jacob and Hofman, Michael S and Lawrentschuk, Nathan and Perera, Marlon and Murphy, Declan G and Eapen, Renu},
title = {The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer},
journal = {Cancers},
year = {2024},
volume = {16},
number = {5},
pages = {939},
doi = {10.3390/cancers16050939}
}
EUVIMED